source
- Parabilis raises $670M in record-setting Nasdaq debut to fund cancer drug developmentParabilis completed a $670 million initial public offering on the Nasdaq, establishing the largest biotech debut in the exchange’s history. The offering drew strong investor demand even as attenti…
- US judge upholds law to curb hospital drug prices as shortage trends show mixed signalsA federal judge in Washington rejected a pharmaceutical industry challenge to a state law aimed at lowering hospital drug prices, leaving the pricing reforms in place. Data from a recent analysis…